Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ciarleglio, V. A. Martino, M. R. Refini, L. Bracci, A. S. Melani, P. Sestini (Siena, Italy). Smoking cessation in patients with respiratory diseases. Eur Respir J 2005; 26: Suppl. 49, 1685

Member's Comments

No comment yet.

Related content which might interest you: COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Recommendations for smoking cessation treatment in respiratory patients Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006 Overview of smoking-related disease Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Evidence for harm reduction in diseased smokers Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited Year: 2007 Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy Source: Eur Respir J 2007; 29: 390-417 Year: 2007 Introductory lecture: Nicotine addiction treatment in COPD patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 Does chronic obstructive pulmonary disease (COPD) impact on women smoking cessation approach? Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018 Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Success of smoking cessation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Smoking abstinence in patients with chronic airway obstructive disease Source: Annual Congress 2006 - How to treat tobacco smokers Year: 2006 Epidemiology of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 17: 982-994 Year: 2001 Effectiveness of a smoking cessation programme for COPD (SMOCC) in routine general practice Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Developing COPD – a 25 year follow-up study of the general population Source: Annual Congress 2005 - Better understanding of lung function decline and COPD Year: 2005 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 “Lung age” – a motivational smoking cessation tool in smokers with chronic obstructive pulmonary disease Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018 Fully financed smoking cessation for patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020 The SMOKE study: 1 year evaluation of an intensive multi-component smoking cessation programme for COPD outpatients Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005